Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan

Intervirology. 2001;44(6):327-32. doi: 10.1159/000050066.

Abstract

Objectives: The aim of this study was to elucidate the seroprevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infection in Uzbekistan and to explore whether there is a correlation between those blood-borne agents and socioeconomic risk factors.

Methods: One thousand nine hundred and eighteen subjects were studied. The subjects were divided into a low-risk group, a high-risk group and a patient group. Sera were tested for HBV surface antigen (HBsAg), anti-HCV, and anti-HIV.

Results: The seroprevalence of HBsAg, anti-HCV, and anti-HIV in the general population was 13.3, 13.1 and 0%, respectively. The anti-HCV infection rate was significantly higher in intravenous drug users (62.7%) than in prostitutes (9.2%), homosexuals (11.1%), and medical laboratory employees (12.5%) (p < 0.01). In the low-risk group, positivity for anti-HCV increased with age from 2.2% in the 15- to 20-year-olds up to the highest rate of 17.6% in the 31- to 40-year-olds; the positivity then decreased to 0% in the group over 60 years of age. In the high-risk group, the positivity for anti-HCV in the age groups under 40 years was approximately 30% and significantly higher than in the low-risk group (p < 0.01). Risk factors for transmission of HCV were medical treatment in the low-risk group, drug abuse in the high-risk group, and both in the patient group.

Conclusions: This study demonstrates that the seroprevalence of HBV and HCV infection is high, whereas HIV infection is yet uncommon in Uzbekistan.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Female
  • HIV Antibodies / blood
  • HIV Infections / blood
  • HIV Infections / epidemiology*
  • HIV Infections / immunology
  • Hepacivirus / immunology
  • Hepatitis B / blood
  • Hepatitis B / epidemiology*
  • Hepatitis B / immunology
  • Hepatitis B Surface Antigens / blood
  • Hepatitis B virus / immunology
  • Hepatitis C / blood
  • Hepatitis C / embryology
  • Hepatitis C / epidemiology*
  • Hepatitis C / immunology
  • Hepatitis C Antibodies / blood
  • Humans
  • Male
  • Middle Aged
  • Risk Factors
  • Seroepidemiologic Studies
  • Uzbekistan / epidemiology

Substances

  • HIV Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis C Antibodies